Biotech professionals must progress their drug discovery R&D timelines fast in order to make the best use of their funding and IP. We help you take the jump from petri dish to mammal in-vivo models with confidence and more quickly than going straight to rodent models.

Consumer goods, manufacturing and other industries investing in R&D want to put the best quality, eco-friendly products out on the market. However, testing your compounds for impact on environmental and human health can lead to overly complex, ethically challenging and time-consuming studies with animal models. C. elegans offers an ethical approach that can get the data you need on your compound in as little as three weeks.

The pressure on drug developers is greater than ever and pharma need to look to innovative new tools to stay ahead of the competition. C. elegans offer an NC3R-approved avenue to fast-track preclinical research, to save you from or reduce your reliance on high-investment rodent studies.

You want to progress your research and improve lab operations but access to the right technologies, technological expertise and the time to juggle everything is challenging. We offer high-quality C. elegans lab services, transgenics services, and machine leasing of our unique automated technology to help you access the resources you need to stay top of your field.